Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bharat Biotech and GSK pledge to lower malaria vaccine price under Gavi replenishment initiative
RTS,S vaccine price to be reduced to below $5 by 2028 through manufacturing scale-up and technology transfer
Lupin receives approval from US FDA for Prucalopride Tablets
The approved tablets are bioequivalent to Takeda’s Motegrity and will be manufactured at Lupin’s Goa facility
Yeztugo holds potential to address key unmet needs for PrEP usage including adherence issues:…
Twice-yearly injectable therapy may improve adherence and expand access to HIV prevention, but affordability and insurance…
Utopia Therapeutics secures $1.5 million seed funding from whale tank to advance obesity vaccine…
Investment will accelerate preclinical development of UT009 and support early-stage trials for novel immunotherapeutic targeting…
Novo Nordisk launches Wegovy for chronic weight management and cardiovascular risk reduction in…
Wegovy, a once-weekly semaglutide injection, is reportedly the first GLP-1 receptor agonist in India approved for both long-term…
CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion in 2024, reveals…
GlobalData attributes surge in CNS oligonucleotide licensing to increased adoption of ASOs and siRNAs, alongside advancements in…
Rubicon Research acquires Alkem’s Pithampur manufacturing facility for ₹149 crores
The acquisition expands Rubicon’s manufacturing footprint and capabilities in high-potency formulations, supporting its US market…
Glenmark launches TEVIMBRA in India for treatment of advanced lung and oesophageal cancer
Glenmark Pharmaceuticals introduces tislelizumab following CDSCO approval, expanding its oncology portfolio with its first…
CORONA Remedies appoints four independent directors to strengthen board governance
Ameetkumar H Desai, Bhaskar V Iyer, Shirish G Belapure, and Monica H Kanuga join CORONA Remedies’ Board as Independent Directors…
Why most extractables & leachables studies fail regulatory review-and how to fix them
Madhu of SG Pharma Solutions highlights why extractables and leachables (E&L) studies frequently fail regulatory review and…